Ragada Damanawi-El

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

End Point Selection in ADPKD Clinical Trials.

End Point Selection in ADPKD Clinical Trials.

Journal: Kidney international reports

Published: June 16, 2025

Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.

Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.

Journal: Trials

Published: May 03, 2025

Metformin for preventing the progression of chronic kidney disease.

Metformin for preventing the progression of chronic kidney disease.

Journal: The Cochrane database of systematic reviews

Published: June 05, 2024

Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease.

Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease.

Journal: Clinical kidney journal

Published: September 21, 2020

Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD.

Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD.

Journal: Kidney international reports

Published: July 02, 2020

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.

Journal: QJM : monthly journal of the Association of Physicians

Published: January 21, 2020

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.

Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: January 20, 2020

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.

Journal: QJM : monthly journal of the Association of Physicians

Published: August 10, 2019

Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.

Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.

Journal: BMJ open

Published: May 11, 2018

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.

Journal: Clinical kidney journal

Published: September 08, 2016

Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease.

Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease.

Journal: Nephron

Published: September 17, 2014

Successful restoration of arteriovenous dialysis access patency after late intervention.

Successful restoration of arteriovenous dialysis access patency after late intervention.

Journal: Clinical kidney journal

Published: August 14, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026